Announcements Trials
Browse Landscape

Phase

Phase 3 62Phase 2 59Phase NA 28Phase 1/2 6Phase 2/3 4Phase 1 3Phase EARLY_PHASE1 1

Status

Completed 135Terminated 21Withdrawn 9Unknown 7Active not recruiting 7Recruiting 3Not yet recruiting 2Suspended 1

Sponsor Class

INDUSTRY 1126OTHER 994NIH 57OTHER_GOV 11NETWORK 3FED 2INDIV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1HIV Infections 1Astrocytoma 1

Interventions

fludarabine 2Specimen Handling 2merphos 1imetelstat 1hydrocortisone hemisuccinate 1axicabtagene ciloleucel 1Spinal Puncture 1Radiotherapy 1Radiation 1Methotrexate 1Magnetic Resonance Spectroscopy 1Leucovorin 1Hydrocortisone 1GRN163L peptide 1Cytarabine 1Cyclophosphamide 1Biopsy 1AZD1390 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × NETWORK × Clear all
NCT06894979 2026-05-15

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Children's Oncology Group

Phase 1 Recruiting
54 enrolled
CNS

Astrocytoma

NCT06247787 2026-04-20

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Children's Oncology Group

Phase 1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

NCT05077527 2026-04-14

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡